To our knowledge, this is the first report that shows a significant correlation between hepatic increased Wnt5a protein and mRNA expression and development of NASH, especially associated with T2DM in the liver tissue. This evidence concerns the gene WNT5A and metabolic dysfunction-associated steatohepatitis.